SMA
BIOSU

Sage Mountain Advisors’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Sage Mountain Advisors’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,610
Closed -$253K – 512
2022
Q2 		$253K Hold
25,610
– – 0.04% 371
2022
Q1 		$255K Sell
25,610
-36,500
-59% -$365K 0.04% 415
2021
Q4 		$621K Buy
+62,110
New +$622K 0.07% 260

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bracebridge Capital LLC
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
Cubist Systematic Strategies
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Sage Mountain Advisors's BIOSU Position: Q3 2022 in Review

Sage Mountain Advisors sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q3 2022, closing a stake of 25,610 shares — an estimated $253K sold.

Sage Mountain Advisors first reported a position in BIOSU in Q4 2021 and held it in 3 quarters. The position peaked at $621K in Q4 2021. 15 funds tracked by Wall St. Rank hold BIOSU as of Q3 2022.

  • Sage Mountain Advisors reported no remaining BioPlus Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Sage Mountain Advisors sold 25,610 BioPlus Acquisition Corp. Unit shares in Q3 2022, an estimated $253K.
  • Sage Mountain Advisors first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
  • Sage Mountain Advisors's BioPlus Acquisition Corp. Unit position peaked at $621K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q3 2022.

Based on Sage Mountain Advisors's 13F filing for Q3 2022, filed 31 Oct 2022.